137 related articles for article (PubMed ID: 9425391)
1. Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumours.
Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
Clin Endocrinol (Oxf); 1997 Nov; 47(5):523-8. PubMed ID: 9425391
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
[TBL] [Abstract][Full Text] [Related]
3. Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours.
Nikiforova MN; Nikiforov YE; Biddinger P; Gnepp DR; Grosembacher LA; Wajchenberg BL; Fagin JA; Cohen RM
Clin Endocrinol (Oxf); 1999 Jul; 51(1):27-33. PubMed ID: 10468962
[TBL] [Abstract][Full Text] [Related]
4. Mutational analyses of WNT7A and HDAC11 as candidate tumour suppressor genes in sporadic malignant pancreatic endocrine tumours.
Lindberg D; Akerström G; Westin G
Clin Endocrinol (Oxf); 2007 Jan; 66(1):110-4. PubMed ID: 17201809
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours.
Jaïs P; Terris B; Ruszniewski P; LeRomancer M; Reyl-Desmars F; Vissuzaine C; Cadiot G; Mignon M; Lewin MJ
Eur J Clin Invest; 1997 Aug; 27(8):639-44. PubMed ID: 9279525
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors.
Bartsch D; Hahn SA; Danichevski KD; Ramaswamy A; Bastian D; Galehdari H; Barth P; Schmiegel W; Simon B; Rothmund M
Oncogene; 1999 Apr; 18(14):2367-71. PubMed ID: 10327057
[TBL] [Abstract][Full Text] [Related]
8. A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb.
O'Connor DP; Kay EW; Leader M; Murphy GM; Atkins GJ; Mabruk MJ
Mol Pathol; 2001 Jun; 54(3):165-9. PubMed ID: 11376129
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 22q in pancreatic endocrine tumors: identification of a homozygous deletion and potential prognostic associations of allelic deletions.
Wild A; Langer P; Celik I; Chaloupka B; Bartsch DK
Eur J Endocrinol; 2002 Oct; 147(4):507-13. PubMed ID: 12370114
[TBL] [Abstract][Full Text] [Related]
10. A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.
Raef H; Zou M; Baitei EY; Al-Rijjal RA; Kaya N; Al-Hamed M; Monies D; Abu-Dheim NN; Al-Hindi H; Al-Ghamdi MH; Meyer BF; Shi Y
Clin Endocrinol (Oxf); 2011 Dec; 75(6):791-800. PubMed ID: 21627674
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at microsatellite marker sites for tumour suppressor genes in oesophageal adenocarcinoma.
Morgan RJ; Newcomb PV; Bailey M; Hardwick RH; Alderson D
Eur J Surg Oncol; 1998 Feb; 24(1):34-7. PubMed ID: 9542513
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1.
Bale AE; Norton JA; Wong EL; Fryburg JS; Maton PN; Oldfield EH; Streeten E; Aurbach GD; Brandi ML; Friedman E
Cancer Res; 1991 Feb; 51(4):1154-7. PubMed ID: 1671755
[TBL] [Abstract][Full Text] [Related]
13. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin.
Harvey M; Vogel H; Lee EY; Bradley A; Donehower LA
Cancer Res; 1995 Mar; 55(5):1146-51. PubMed ID: 7867001
[TBL] [Abstract][Full Text] [Related]
14. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 11 allele loss in sporadic insulinoma.
Patel P; O'Rahilly S; Buckle V; Nakamura Y; Turner RC; Wainscoat JS
J Clin Pathol; 1990 May; 43(5):377-8. PubMed ID: 2164532
[TBL] [Abstract][Full Text] [Related]
17. Co-deletions of the retinoblastoma gene and Wilms' tumor gene and rearrangement of the Krev-1 gene in a human insulinoma.
Iwamura Y; Futagawa T; Kaneko M; Nakagawa K; Kawai K; Yamashita K; Nakamura T; Hayashi H
Jpn J Clin Oncol; 1992 Feb; 22(1):6-9. PubMed ID: 1573790
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic endocrine tumours: evidence for a tumour suppressor pathogenesis and for a tumour suppressor gene on chromosome 17p.
Beghelli S; Pelosi G; Zamboni G; Falconi M; Iacono C; Bordi C; Scarpa A
J Pathol; 1998 Sep; 186(1):41-50. PubMed ID: 9875139
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas.
Zhuang Z; Vortmeyer AO; Pack S; Huang S; Pham TA; Wang C; Park WS; Agarwal SK; Debelenko LV; Kester M; Guru SC; Manickam P; Olufemi SE; Yu F; Heppner C; Crabtree JS; Skarulis MC; Venzon DJ; Emmert-Buck MR; Spiegel AM; Chandrasekharappa SC; Collins FS; Burns AL; Marx SJ; Lubensky IA
Cancer Res; 1997 Nov; 57(21):4682-6. PubMed ID: 9354421
[TBL] [Abstract][Full Text] [Related]
20. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.
Cryns VL; Thor A; Xu HJ; Hu SX; Wierman ME; Vickery AL; Benedict WF; Arnold A
N Engl J Med; 1994 Mar; 330(11):757-61. PubMed ID: 7906387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
